U.S. Physical Therapy (NYSE:USPH – Get Free Report)‘s stock had its “outperform” rating reissued by equities research analysts at Barrington Research in a research note issued on Friday,Benzinga reports. They presently have a $103.00 price target on the stock. Barrington Research’s price target points to a potential upside of 19.41% from the stock’s previous close.
Other equities analysts also recently issued reports about the stock. JPMorgan Chase & Co. dropped their price target on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a research note on Monday, November 24th. Weiss Ratings reiterated a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, January 21st. Finally, Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Monday, December 15th. Four equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $105.33.
View Our Latest Stock Analysis on USPH
U.S. Physical Therapy Stock Performance
Institutional Trading of U.S. Physical Therapy
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Hantz Financial Services Inc. lifted its stake in shares of U.S. Physical Therapy by 56.4% in the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock valued at $29,000 after buying an additional 132 shares during the period. Cullen Frost Bankers Inc. lifted its position in shares of U.S. Physical Therapy by 171.8% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company’s stock worth $35,000 after acquiring an additional 280 shares during the period. Advisory Services Network LLC acquired a new stake in shares of U.S. Physical Therapy during the 3rd quarter worth approximately $39,000. EverSource Wealth Advisors LLC increased its position in shares of U.S. Physical Therapy by 68.8% during the third quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock valued at $40,000 after purchasing an additional 192 shares during the period. Finally, GAMMA Investing LLC increased its position in shares of U.S. Physical Therapy by 207.1% during the fourth quarter. GAMMA Investing LLC now owns 516 shares of the company’s stock valued at $40,000 after purchasing an additional 348 shares during the period.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
Further Reading
- Five stocks we like better than U.S. Physical Therapy
- 3 Signs You May Want to Switch Financial Advisors
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
